封面
市场调查报告书
商品编码
1565643

生命科学市场中的製造执行系统,按解决方案类型、部署、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Manufacturing Execution System in Life Sciences Market, By Solution Type, By Deployment, By End-user, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023年生命科学製造执行系统市场规模为35.3043亿美元,2024年至2032年复合年增长率为12.20%。

生命科学市场的製造执行系统-市场动态

严格的监管要求

美国 FDA(食品药物管理局)和欧洲 EMA(欧洲药品管理局)等监管机构对製造流程实施严格的指导方针,以确保生命科学产品的安全性和有效性。 MES 系统透过提供可追溯性、文件和稽核追踪来帮助製造商遵守这些法规。例如,FDA 的 21 CFR Part 11 法规要求以安全且可追踪的方式维护电子记录和签名,而 MES 系统可以很好地处理这些记录和签名。对法规遵从性的日益重视预计将推动 MES 系统的采用,预计未来五年采用率将增加 12%。

提高生产效率和品质控制的需求

对提高生产效率和品质控制的需求不断增长是生命科学领域 MES 市场的另一个关键驱动力。随着製药和生物技术产品的复杂性增加,製造商需要先进的系统来管理和优化其生产流程。 MES 系统可以即时监控和控制生产,减少停机时间并最大限度地减少错误。根据 2023 年的一项调查,超过 65% 的生命科学製造商表示 MES 系统显着提高了生产效率,并将批次放行时间缩短了高达 25%。这种对效率和品质控制的推动预计将推动未来几年的市场成长。

生命科学市场中的製造执行系统 - 关键见解

根据我们的研究分析师分享的分析,预计全球市场在预测期内(2024-2032)每年将以 12.20% 左右的复合年增长率成长

根据解决方案类型细分,预计软体将在 2023 年显示最大的市场份额

基于部署细分,2023年云端部署为主导类型

按地区划分,北美是 2023 年的主要收入来源

生命科学市场中的製造执行系统 - 細項分析:

生命科学市场的全球製造执行系统根据解决方案类型、部署、最终用户和区域进行细分。

根据解决方案类型,市场分为四类:软体和服务。软体部分是生命科学市场 MES 的关键组成部分,其驱动力是对能够处理复杂製造流程并确保法规遵循的先进解决方案的需求。此细分市场的主要驱动力是软体功能的不断发展,包括即时资料分析、预测性维护以及与 ERP(企业资源规划)和 QMS(品质管理系统)等其他企业系统的整合等功能。这些功能可协助製造商优化生产、降低营运成本并确保产品品质。

根据部署,市场分为两类:本地部署、基于云端的部署和混合部署。与传统的本地系统相比,基于云端的 MES 解决方案具有多种优势,包括较低的前期成本、可扩展性以及更容易与其他基于云端的应用程式整合。远端存取 MES 系统的能力,加上增强的资料安全性和合规性功能,使得基于云端的解决方案对生命科学製造商特别有吸引力。

生命科学市场的製造执行系统 - 地理洞察

在中国、印度和日本等国家製药和生物技术产业快速扩张的推动下,亚太地区正在成为生命科学市场 MES 的关键成长区域。该地区日益关注改进製造工艺,加上政府提高当地生产能力的倡议,正在推动对先进 MES 解决方案的需求。此外,该地区合约製造组织 (CMO) 数量的增加和仿製药生产的增加也促进了 MES 市场的成长。

生命科学市场中的製造执行系统-竞争格局:

生命科学产业的全球 MES 市场竞争激烈,几个主要参与者占据市场主导地位。主要产业参与者包括西门子股份公司、罗克韦尔自动化、霍尼韦尔国际公司、Werum IT Solutions GmbH(Korber AG 旗下公司)和艾默生电气公司。以加强其市场地位。例如,西门子公司一直透过策略性收购以及与领先的生命科学公司建立合作伙伴关係来扩大其MES产品组合,而罗克韦尔自动化则透过人工智慧驱动的解决方案增强其MES能力,以满足对智慧製造系统不断成长的需求。竞争格局的特点是不断的技术进步和旨在满足生命科学产业不断变化的需求的新软体解决方案的推出。

最新进展:

2024 年 5 月,Korber Pharma 和西门子在 ABI Research 的製药、生物技术以及细胞和基因製造 MES 软体竞争排名中处于领先地位。

2024 年 1 月,全球最大的致力于工业自动化和数位转型的公司罗克韦尔自动化今天宣布,作为正在进行的全公司数位化计画的一部分,Rottendorf Pharma GmbH 正在推出 FactoryTalk PharmaSuite(R) 製造执行系统来自罗克韦尔自动化的综合电子批量记录解决方案。

目录

第 1 章:生命科学市场概述中的製造执行系统

  • 研究范围
  • 市场预估年份

第 2 章:执行摘要

  • 市场片段
    • 生命科学市场中的製造执行系统片段(按解决方案类型)
    • 生命科学市场中的製造执行系统部署片段
    • 生命科学市场中的製造执行系统最终使用者片段
    • 按国家/地区分類的生命科学市场片段中的製造执行系统
    • 按地区分類的生命科学市场片段中的製造执行系统
  • 竞争洞察

第 3 章:生命科学中的製造执行系统主要市场趋势

  • 生命科学市场驱动因素中的製造执行系统
    • 市场驱动因素的影响分析
  • 生命科学市场限制中的製造执行系统
    • 市场限制影响分析
  • 生命科学市场机会中的製造执行系统
  • 生命科学市场的製造执行系统未来趋势

第 4 章:生命科学产业研究中的製造执行系统

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章:生命科学市场中的製造执行系统:COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章:生命科学市场格局中的製造执行系统

  • 生命科学製造执行系统市场占有率分析,2023 年
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章:生命科学市场中的製造执行系统 - 按解决方案类型

  • 概述
    • 按解决方案类型分類的细分市场份额分析
    • 软体
    • 服务

第 8 章:生命科学市场中的製造执行系统 - 按部署

  • 概述
    • 按部署分類的细分市场占有率分析
    • 本地部署
    • 基于云端/网路
    • 杂交种

第 9 章:生命科学市场中的製造执行系统 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 製药与生物技术公司
    • 医疗器材公司
    • 其他的

第 10 章:生命科学市场中的製造执行系统 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 生命科学製造执行系统北美主要製造商
    • 北美市场规模和预测(按国家)
    • 北美市场规模和预测(按解决方案类型)
    • 北美市场规模和预测(按部署)
    • 北美市场规模和预测(按最终用户)
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 生命科学製造执行系统欧洲主要製造商
    • 欧洲市场规模和预测(按国家)
    • 欧洲市场规模和预测(按解决方案类型)
    • 欧洲市场规模和预测(按部署)
    • 欧洲市场规模和预测(按最终用户)
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 生命科学製造执行系统亚太地区主要製造商
    • 亚太地区市场规模与预测(按国家)
    • 亚太地区市场规模和预测(按解决方案类型)
    • 亚太地区市场规模与预测(按部署)
    • 亚太地区市场规模和预测(按最终用户)
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 生命科学製造执行系统拉丁美洲主要製造商
    • 拉丁美洲市场规模与预测(按国家)
    • 拉丁美洲市场规模和预测(按解决方案类型)
    • 拉丁美洲市场规模与预测(按部署)
    • 拉丁美洲市场规模和预测(按最终用户)
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 生命科学製造执行系统中东和非洲主要製造商
    • 中东和非洲市场规模及预测(按国家)
    • 中东和非洲市场规模及预测(按解决方案类型)
    • 中东和非洲市场规模和预测(按部署)
    • 中东和非洲市场规模和预测(按最终用户)
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章:关键供应商分析 - 生命科学产业的製造执行系统

  • 竞争仪表板
  • 公司简介
    • ABB
    • Korber AG
    • MasterControl Solutions, Inc.
    • AVEVA Group Limited
    • Cognizant
    • Rockwell Automation
    • Siemens AG
    • Emerson Electric Co.
    • iBase-t
    • Nagarro

第 12 章:360 度分析师视角

第 13 章:附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV3849

REPORT HIGHLIGHT

Manufacturing Execution System in Life Sciences Market size was valued at USD 3,530.43 Million in 2023, expanding at a CAGR of 12.20% from 2024 to 2032.

The Manufacturing Execution System (MES) in the life sciences market refers to specialized software solutions designed to manage and monitor production processes in industries such as pharmaceuticals, biotechnology, and medical devices. MES systems in life sciences are crucial for ensuring compliance with stringent regulatory requirements, improving production efficiency, and maintaining high-quality standards throughout the manufacturing process. These systems provide real-time data collection, monitoring, and control, enabling manufacturers to optimize production workflows, reduce waste, and enhance overall productivity.

Manufacturing Execution System in Life Sciences Market- Market Dynamics

Stringent Regulatory Requirements

Regulatory bodies such as the FDA (Food and Drug Administration) in the United States and the EMA (European Medicines Agency) in Europe impose strict guidelines on manufacturing processes to ensure the safety and efficacy of life sciences products. MES systems help manufacturers comply with these regulations by providing traceability, documentation, and audit trails. For instance, the FDA's 21 CFR Part 11 regulation requires electronic records and signatures to be maintained in a secure and traceable manner, which MES systems are well-equipped to handle. The growing emphasis on regulatory compliance is expected to drive the adoption of MES systems, with a forecasted 12% increase in adoption rates in the next five years.

Demand for Improved Production Efficiency and Quality Control

The increasing demand for improved production efficiency and quality control is another key driver of the MES market in life sciences. As the complexity of pharmaceutical and biotechnological products increases, manufacturers require advanced systems to manage and optimize their production processes. MES systems enable real-time monitoring and control of production, reducing downtime and minimizing errors. According to a 2023 survey, over 65% of life sciences manufacturers reported that MES systems significantly improved their production efficiency and reduced batch release times by up to 25%. This drive towards efficiency and quality control is expected to fuel market growth in the coming years.

Manufacturing Execution System in Life Sciences Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 12.20% over the forecast period (2024-2032)

Based on Solution Type segmentation, Software was predicted to show maximum market share in the year 2023

Based on Deployment segmentation, Cloud-Based deployment was the leading type in 2023

On the basis of Region, North America was the leading revenue generator in 2023

Manufacturing Execution System in Life Sciences Market- Segmentation Analysis:

The Global Manufacturing Execution System in Life Sciences Market is segmented on the basis of Solution Type, Deployment, End-user, and Region.

The market is divided into four categories based on Solution Type: Software and Services. The software segment is a critical component of the MES in the life sciences market, driven by the need for advanced solutions that can handle complex manufacturing processes and ensure regulatory compliance. The primary driver for this segment is the continuous evolution of software capabilities, including features such as real-time data analytics, predictive maintenance, and integration with other enterprise systems like ERP (Enterprise Resource Planning) and QMS (Quality Management System). These features help manufacturers optimize production, reduce operational costs, and ensure product quality.

The market is divided into two categories based on Deployment: On-Premise, Cloud-Based and Hybrid. Cloud-based MES solutions offer several advantages over traditional on-premises systems, including lower upfront costs, scalability, and easier integration with other cloud-based applications. The ability to access MES systems remotely, coupled with enhanced data security and compliance features, makes cloud-based solutions particularly attractive for life sciences manufacturers.

Manufacturing Execution System in Life Sciences Market- Geographical Insights

The Asia Pacific region is emerging as a key growth area for the MES in the life sciences market, driven by the rapid expansion of the pharmaceutical and biotechnology industries in countries like China, India, and Japan. The region's growing focus on improving manufacturing processes, coupled with government initiatives to boost local production capabilities, is fueling the demand for advanced MES solutions. Additionally, the increasing number of contract manufacturing organizations (CMOs) and the rise in generic drug production in the region are contributing to the growth of the MES market.

Manufacturing Execution System in Life Sciences Market- Competitive Landscape:

The global MES market in the life sciences industry is highly competitive, with several key players dominating the market. Major industry players include Siemens AG, Rockwell Automation, Honeywell International Inc., Werum IT Solutions GmbH (a Korber AG company), and Emerson Electric Co. These companies are focusing on innovation, strategic partnerships, and acquisitions to strengthen their market position. For instance, Siemens AG has been expanding its MES portfolio through strategic acquisitions and partnerships with leading life sciences companies, while Rockwell Automation is enhancing its MES capabilities with AI-driven solutions to cater to the growing demand for intelligent manufacturing systems. The competitive landscape is characterized by continuous technological advancements and the introduction of new software solutions designed to meet the evolving needs of the life sciences industry.

Recent Developments:

In May 2024, Korber Pharma and Siemens Take the Lead in ABI Research's MES Software for Pharmaceutical, Biotechnology, and Cell & Gene Manufacturing Competitive Ranking.

In January 2024, Rockwell Automation, Inc., the world's largest company dedicated to industrial automation and digital transformation, today announced that as part of an ongoing company-wide digitalization program, Rottendorf Pharma GmbH is introducing the FactoryTalk PharmaSuite(R) manufacturing execution system from Rockwell Automation, a comprehensive electronic batch recording solution.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MANUFACTURING EXECUTION SYSTEM IN LIFE SCIENCES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • ABB
  • Korber AG
  • MasterControl Solutions, Inc.
  • AVEVA Group Limited
  • Cognizant
  • Rockwell Automation
  • Siemens AG
  • Emerson Electric Co.
  • iBase-t
  • Nagarro

GLOBAL MANUFACTURING EXECUTION SYSTEM IN LIFE SCIENCES MARKET, BY SOLUTION TYPE- MARKET ANALYSIS, 2019 - 2032

  • Software
  • Services

GLOBAL MANUFACTURING EXECUTION SYSTEM IN LIFE SCIENCES MARKET, BY DEPLOYMENT- MARKET ANALYSIS, 2019 - 2032

  • On-Premise
  • Cloud-Based
  • Hybrid

GLOBAL MANUFACTURING EXECUTION SYSTEM IN LIFE SCIENCES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical and Biotechnology Companies
  • Medical Devices Companies
  • Others

GLOBAL MANUFACTURING EXECUTION SYSTEM IN LIFE SCIENCES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Manufacturing Execution System in Life Sciences Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Manufacturing Execution System in Life Sciences Market Snippet by Solution Type
    • 2.1.2. Manufacturing Execution System in Life Sciences Market Snippet by Deployment
    • 2.1.3. Manufacturing Execution System in Life Sciences Market Snippet by End-user
    • 2.1.4. Manufacturing Execution System in Life Sciences Market Snippet by Country
    • 2.1.5. Manufacturing Execution System in Life Sciences Market Snippet by Region
  • 2.2. Competitive Insights

3. Manufacturing Execution System in Life Sciences Key Market Trends

  • 3.1. Manufacturing Execution System in Life Sciences Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Manufacturing Execution System in Life Sciences Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Manufacturing Execution System in Life Sciences Market Opportunities
  • 3.4. Manufacturing Execution System in Life Sciences Market Future Trends

4. Manufacturing Execution System in Life Sciences Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Manufacturing Execution System in Life Sciences Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Manufacturing Execution System in Life Sciences Market Landscape

  • 6.1. Manufacturing Execution System in Life Sciences Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Manufacturing Execution System in Life Sciences Market - By Solution Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Solution Type, 2023 & 2032 (%)
    • 7.1.2. Software
    • 7.1.3. Services

8. Manufacturing Execution System in Life Sciences Market - By Deployment

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Deployment, 2023 & 2032 (%)
    • 8.1.2. On-Premise
    • 8.1.3. Cloud/Web-Based
    • 8.1.4. Hybrid

9. Manufacturing Execution System in Life Sciences Market - By End-user

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-user, 2023 & 2032 (%)
    • 9.1.2. Pharmaceutical & Biotechnology Companies
    • 9.1.3. Medical Device Companies
    • 9.1.4. Others

10. Manufacturing Execution System in Life Sciences Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Manufacturing Execution System in Life Sciences Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Manufacturing Execution System in Life Sciences Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Manufacturing Execution System in Life Sciences Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Manufacturing Execution System in Life Sciences Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Manufacturing Execution System in Life Sciences Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Deployment, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Manufacturing Execution System in Life Sciences Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. ABB
    • 11.2.2. Korber AG
    • 11.2.3. MasterControl Solutions, Inc.
    • 11.2.4. AVEVA Group Limited
    • 11.2.5. Cognizant
    • 11.2.6. Rockwell Automation
    • 11.2.7. Siemens AG
    • 11.2.8. Emerson Electric Co.
    • 11.2.9. iBase-t
    • 11.2.10. Nagarro

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us